Toll Free: 1-888-928-9744
Published: Dec, 2017 | Pages:
103 | Publisher: US Market Insight (UMI)
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022. This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Obsessive-Compulsive Disorder Treatment industry. Major Companies AbbVie Inc. Addex Therapeutics Ltd C4X Discovery Limited F. Hoffmann-La Roche Ltd. Novartis AG Omeros Corporation Rottapharm SpA Sellas Inc. Key Regions North America United States California Texas New York Others Canada Latin America Mexico Brazil Argentina Others Europe Germany United Kingdom France Italy Spain Russia Netherland Others Asia & Pacific China Japan India Korea Australia Southeast Asia Indonesia Thailand Philippines Vietnam Singapore Malaysia Others Africa & Middle East South Africa Egypt Turkey Saudi Arabia Iran Others Main types of products Obsessive-Compulsive Disorder Treatment Market, byX-88178 Obsessive-Compulsive Disorder Treatment Market, bytopertin Obsessive-Compulsive Disorder Treatment Market, by-5542 Obsessive-Compulsive Disorder Treatment Market, bypraglurant IR Obsessive-Compulsive Disorder Treatment Market, byuvoxamine Maleate Obsessive-Compulsive Disorder Treatment Market, by Key Consumers Clinic Hospital Research Center
Table of Contents Global and United States Obsessive-Compulsive Disorder Treatment In-Depth Research Report 2017-2022 Chapter One Global Obsessive-Compulsive Disorder Treatment Market Overview 1.1 Global Obsessive-Compulsive Disorder Treatment Market Sales Volume Revenue and Price 2012-2017 1.2 Obsessive-Compulsive Disorder Treatment, by -88178 2012-2017 1.2.1 Global Obsessive-Compulsive Disorder Treatment Sales Market Share by -88178 2012-2017 1.2.2 Global Obsessive-Compulsive Disorder Treatment Revenue Market Share by -88178 2012-2017 1.2.3 Global Obsessive-Compulsive Disorder Treatment Price by -88178 2012-2017 1.2.4 1.2.5 1.3 Obsessive-Compulsive Disorder Treatment, by opertin 2012-2017 1.3.1 Global Obsessive-Compulsive Disorder Treatment Sales Market Share by opertin 2012-2017 1.3.2 Global Obsessive-Compulsive Disorder Treatment Revenue Market Share by opertin 2012-2017 1.3.3 Global Obsessive-Compulsive Disorder Treatment Price by opertin 2012-2017 1.3.4 1.3.5 1.4 Obsessive-Compulsive Disorder Treatment, by 5542 2012-2017 1.4.1 Global Obsessive-Compulsive Disorder Treatment Sales Market Share by 5542 2012-2017 1.4.2 Global Obsessive-Compulsive Disorder Treatment Revenue Market Share by 5542 2012-2017 1.4.3 Global Obsessive-Compulsive Disorder Treatment Price by 5542 2012-2017 1.4.4 1.4.5 1.5 Obsessive-Compulsive Disorder Treatment, by raglurant IR 2012-2017 1.5.1 Global Obsessive-Compulsive Disorder Treatment Sales Market Share by raglurant IR 2012-2017 1.5.2 Global Obsessive-Compulsive Disorder Treatment Revenue Market Share by raglurant IR 2012-2017 1.5.3 Global Obsessive-Compulsive Disorder Treatment Price by raglurant IR 2012-2017 1.5.4 1.5.5 1.6 Obsessive-Compulsive Disorder Treatment, by voxamine Maleate 2012-2017 1.6.1 Global Obsessive-Compulsive Disorder Treatment Sales Market Share by voxamine Maleate 2012-2017 1.6.2 Global Obsessive-Compulsive Disorder Treatment Revenue Market Share by voxamine Maleate 2012-2017 1.6.3 Global Obsessive-Compulsive Disorder Treatment Price by voxamine Maleate 2012-2017 1.6.4 1.6.5 Chapter Two United States Obsessive-Compulsive Disorder Treatment Market Overview 2.1 United States Obsessive-Compulsive Disorder Treatment Market Sales Volume Revenue and Price 2012-2017 2.2 Obsessive-Compulsive Disorder Treatment, by -88178 2012-2017 2.2.1 United States Obsessive-Compulsive Disorder Treatment Sales Market Share by -88178 2012-2017 2.2.2 United States Obsessive-Compulsive Disorder Treatment Revenue Market Share by -88178 2012-2017 2.2.3 United States Obsessive-Compulsive Disorder Treatment Price by -88178 2012-2017 2.2.4 2.2.5 2.3 Obsessive-Compulsive Disorder Treatment, by opertin 2012-2017 2.3.1 United States Obsessive-Compulsive Disorder Treatment Sales Market Share by opertin 2012-2017 2.3.2 United States Obsessive-Compulsive Disorder Treatment Revenue Market Share by opertin 2012-2017 2.3.3 United States Obsessive-Compulsive Disorder Treatment Price by opertin 2012-2017 2.3.4 2.3.5 2.4 Obsessive-Compulsive Disorder Treatment, by 5542 2012-2017 2.4.1 United States Obsessive-Compulsive Disorder Treatment Sales Market Share by 5542 2012-2017 2.4.2 United States Obsessive-Compulsive Disorder Treatment Revenue Market Share by 5542 2012-2017 2.4.3 United States Obsessive-Compulsive Disorder Treatment Price by 5542 2012-2017 2.4.4 2.4.5 2.5 Obsessive-Compulsive Disorder Treatment, by raglurant IR 2012-2017 2.5.1 United States Obsessive-Compulsive Disorder Treatment Sales Market Share by raglurant IR 2012-2017 2.5.2 United States Obsessive-Compulsive Disorder Treatment Revenue Market Share by raglurant IR 2012-2017 2.5.3 United States Obsessive-Compulsive Disorder Treatment Price by raglurant IR 2012-2017 2.5.4 2.5.5 2.6 Obsessive-Compulsive Disorder Treatment, by voxamine Maleate 2012-2017 2.6.1 United States Obsessive-Compulsive Disorder Treatment Sales Market Share by voxamine Maleate 2012-2017 2.6.2 United States Obsessive-Compulsive Disorder Treatment Revenue Market Share by voxamine Maleate 2012-2017 2.6.3 United States Obsessive-Compulsive Disorder Treatment Price by voxamine Maleate 2012-2017 2.6.4 2.6.5 Chapter Three Obsessive-Compulsive Disorder Treatment by Regions 2012-2017 3.1 Global Obsessive-Compulsive Disorder Treatment Sales Market Share by Regions 2012-2017 3.2 Global Obsessive-Compulsive Disorder Treatment Revenue Market Share by Regions 2012-2017 3.3 Global Obsessive-Compulsive Disorder Treatment Price by Regions 2012-2017 3.4 North America 3.4.1 United States 3.4.1.1 California 3.4.1.2 Texas 3.4.1.3 New York 3.4.1.4 Others in United States 3.4.2 Canada 3.5 Latin America 3.5.1 Mexico 3.5.2 Brazil 3.5.3 Argentina 3.5.4 Others in Latin America 3.6 Europe 3.6.1 Germany 3.6.2 United Kingdom 3.6.3 France 3.6.4 Italy 3.6.5 Spain 3.6.6 Russia 3.6.7 Netherland 3.6.8 Others in Europe 3.7 Asia & Pacific 3.7.1 China 3.7.2 Japan 3.7.3 India 3.7.4 Korea 3.7.5 Australia 3.7.6 Southeast Asia 3.7.6.1 Indonesia 3.7.6.2 Thailand 3.7.6.3 Philippines 3.7.6.4 Vietnam 3.7.6.5 Singapore 3.7.6.6 Malaysia 3.7.6.7 Others in Southeast Asia 3.8 Africa & Middle East 3.8.1 South Africa 3.8.2 Egypt 3.8.3 Turkey 3.8.4 Saudi Arabia 3.8.5 Iran 3.8.6 Others in Africa & Middle East Chapter Four Global Obsessive-Compulsive Disorder Treatment by Companies 2012-2017 4.1 Global Obsessive-Compulsive Disorder Treatment Sales Volume Market Share by Companies 2012-2017 4.2 Global Obsessive-Compulsive Disorder Treatment Revenue Share by Companies 2012-2017 4.3 Global Top Companies Obsessive-Compulsive Disorder Treatment Key Product Model and Market Performance 4.4 Global Top Companies Obsessive-Compulsive Disorder Treatment Key Target Consumers and Market Performance Chapter Five United States Obsessive-Compulsive Disorder Treatment by Companies 2012-2017 5.1 United States Obsessive-Compulsive Disorder Treatment Sales Volume Market Share by Companies 2012-2017 5.2 United States Obsessive-Compulsive Disorder Treatment Revenue Share by Companies 2012-2017 5.3 United States Top Companies Obsessive-Compulsive Disorder Treatment Key Product Model and Market Performance 5.4 United States Top Companies Obsessive-Compulsive Disorder Treatment Key Target Consumers and Market Performance Chapter Six Global Obsessive-Compulsive Disorder Treatment by Consumer 2012-2017 6.1 Global Obsessive-Compulsive Disorder Treatment Sales Market Share by Consumer 2012-2017 6.2 Clinic 6.3 Hospital 6.4 Research Center 6.5 Consuming Habit and Preference Chapter Seven Global Obsessive-Compulsive Disorder Treatment by Consumer 2012-2017 7.1 Global Obsessive-Compulsive Disorder Treatment Sales Market Share by Consumer 2012-2017 7.2 Clinic 7.3 Hospital 7.4 Research Center 7.5 Consuming Habit and Preference Chapter Eight Top Companies Profile 8.1 AbbVie Inc. 8.1.1 AbbVie Inc. Company Details and Competitors 8.1.2 AbbVie Inc. Key Obsessive-Compulsive Disorder Treatment Models and Performance 8.1.3 AbbVie Inc. Obsessive-Compulsive Disorder Treatment Business SWOT Analysis and Forecast 8.1.4 AbbVie Inc. Obsessive-Compulsive Disorder Treatment Sales Volume Revenue Price Cost and Gross Margin 8.2 Addex Therapeutics Ltd 8.2.1 Addex Therapeutics Ltd Company Details and Competitors 8.2.2 Addex Therapeutics Ltd Key Obsessive-Compulsive Disorder Treatment Models and Performance 8.2.3 Addex Therapeutics Ltd Obsessive-Compulsive Disorder Treatment Business SWOT Analysis and Forecast 8.2.4 Addex Therapeutics Ltd Obsessive-Compulsive Disorder Treatment Sales Volume Revenue Price Cost and Gross Margin 8.3 C4X Discovery Limited 8.3.1 C4X Discovery Limited Company Details and Competitors 8.3.2 C4X Discovery Limited Key Obsessive-Compulsive Disorder Treatment Models and Performance 8.3.3 C4X Discovery Limited Obsessive-Compulsive Disorder Treatment Business SWOT Analysis and Forecast 8.3.4 C4X Discovery Limited Obsessive-Compulsive Disorder Treatment Sales Volume Revenue Price Cost and Gross Margin 8.4 F. Hoffmann-La Roche Ltd. 8.4.1 F. Hoffmann-La Roche Ltd. Company Details and Competitors 8.4.2 F. Hoffmann-La Roche Ltd. Key Obsessive-Compulsive Disorder Treatment Models and Performance 8.4.3 F. Hoffmann-La Roche Ltd. Obsessive-Compulsive Disorder Treatment Business SWOT Analysis and Forecast 8.4.4 F. Hoffmann-La Roche Ltd. Obsessive-Compulsive Disorder Treatment Sales Volume Revenue Price Cost and Gross Margin 8.5 Novartis AG 8.5.1 Novartis AG Company Details and Competitors 8.5.2 Novartis AG Key Obsessive-Compulsive Disorder Treatment Models and Performance 8.5.3 Novartis AG Obsessive-Compulsive Disorder Treatment Business SWOT Analysis and Forecast 8.5.4 Novartis AG Obsessive-Compulsive Disorder Treatment Sales Volume Revenue Price Cost and Gross Margin 8.6 Omeros Corporation 8.6.1 Omeros Corporation Company Details and Competitors 8.6.2 Omeros Corporation Key Obsessive-Compulsive Disorder Treatment Models and Performance 8.6.3 Omeros Corporation Obsessive-Compulsive Disorder Treatment Business SWOT Analysis and Forecast 8.6.4 Omeros Corporation Obsessive-Compulsive Disorder Treatment Sales Volume Revenue Price Cost and Gross Margin 8.7 Rottapharm SpA 8.7.1 Rottapharm SpA Company Details and Competitors 8.7.2 Rottapharm SpA Key Obsessive-Compulsive Disorder Treatment Models and Performance 8.7.3 Rottapharm SpA Obsessive-Compulsive Disorder Treatment Business SWOT Analysis and Forecast 8.7.4 Rottapharm SpA Obsessive-Compulsive Disorder Treatment Sales Volume Revenue Price Cost and Gross Margin 8.8 Sellas Inc. 8.8.1 Sellas Inc. Company Details and Competitors 8.8.2 Sellas Inc. Key Obsessive-Compulsive Disorder Treatment Models and Performance 8.8.3 Sellas Inc. Obsessive-Compulsive Disorder Treatment Business SWOT Analysis and Forecast 8.8.4 Sellas Inc. Obsessive-Compulsive Disorder Treatment Sales Volume Revenue Price Cost and Gross Margin Chapter Nine Industry Chain and Supply Chain 9.1 Obsessive-Compulsive Disorder Treatment Industry Chain Structure 9.1.1 R&D 9.1.2 Raw Materials (Components) 9.1.3 Manufacturing Plants 9.1.4 Regional Trading (Import Export and Local Sales) 9.1.5 Online Sales Channel 9.1.6 Offline Channel 9.1.7 End Users 9.2 Obsessive-Compulsive Disorder Treatment Manufacturing 9.2.1 Key Components 9.2.2 Assembly Manufacturing 9.3 Consumer Preference 9.4 Behavioral Habits 9.5 Marketing Environment Chapter Ten Global Obsessive-Compulsive Disorder Treatment Market Size (Sales and Revenue) Forecast (2017-2022) 10.1 Global Obsessive-Compulsive Disorder Treatment Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022) 10.2 Global Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by Regions (2017-2022) 10.3 Global Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by Application (2017-2022) 10.4 Global Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by -88178 (2017-2022) 10.5 Global Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by opertin (2017-2022) 10.6 Global Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by 5542 (2017-2022) 10.7 Global Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by raglurant IR (2017-2022) 10.8 Global Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by voxamine Maleate (2017-2022) Chapter Eleven United States Obsessive-Compulsive Disorder Treatment Market Size (Sales and Revenue) Forecast (2017-2022) 11.1 United States Obsessive-Compulsive Disorder Treatment Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022) 11.2 United States Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by Regions (2017-2022) 11.3 United States Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by Application (2017-2022) 11.4 United States Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by -88178 (2017-2022) 11.5 United States Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by opertin (2017-2022) 11.6 United States Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by 5542 (2017-2022) 11.7 United States Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by raglurant IR (2017-2022) 11.8 United States Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by voxamine Maleate (2017-2022) Chapter Twelve Development Trend and Research Conclusion 12.1 Development Trend 12.2 Research Conclusion Chapter Thirteen Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer
List of Tables and Figures Table Global Obsessive-Compulsive Disorder Treatment Sales Volume (K Pcs), Revenue (Million USD) and Price (USD/Pcs)(2012-2017) Figure Global Obsessive-Compulsive Disorder Treatment Revenue (Million USD) and Growth Rate (2012-2017) Figure Global Obsessive-Compulsive Disorder Treatment Sales Volume (K Pcs) and Growth Rate (2012-2017) Table Global Obsessive-Compulsive Disorder Treatment Sales (K Pcs) by -88178 (2012-2017) Table Global Obsessive-Compulsive Disorder Treatment Sales Market Share by -88178 (2012-2017) Figure Global Obsessive-Compulsive Disorder Treatment Sales Market Share by -88178 in 2016 Table Global Obsessive-Compulsive Disorder Treatment Revenue (Million USD) by -88178 (2012-2017) Table Global Obsessive-Compulsive Disorder Treatment Revenue Market Share by -88178 (2012-2017) Figure Global Obsessive-Compulsive Disorder Treatment Revenue Market Share by -88178 in 2016 Table Global Obsessive-Compulsive Disorder Treatment Price (USD/Pcs) by -88178 (2012-2017) Table Global Obsessive-Compulsive Disorder Treatment Sales (K Pcs) by opertin (2012-2017) Table Global Obsessive-Compulsive Disorder Treatment Sales Market Share by opertin (2012-2017) Figure Global Obsessive-Compulsive Disorder Treatment Sales Market Share by opertin in 2016 Table Global Obsessive-Compulsive Disorder Treatment Revenue (Million USD) by opertin (2012-2017) Table Global Obsessive-Compulsive Disorder Treatment Revenue Market Share by opertin (2012-2017) Figure Global Obsessive-Compulsive Disorder Treatment Revenue Market Share by opertin in 2016 Table Global Obsessive-Compulsive Disorder Treatment Price (USD/Pcs) by opertin (2012-2017) Table Global Obsessive-Compulsive Disorder Treatment Sales (K Pcs) by 5542 (2012-2017) Table Global Obsessive-Compulsive Disorder Treatment Sales Market Share by 5542 (2012-2017) Figure Global Obsessive-Compulsive Disorder Treatment Sales Market Share by 5542 in 2016 Table Global Obsessive-Compulsive Disorder Treatment Revenue (Million USD) by 5542 (2012-2017) Table Global Obsessive-Compulsive Disorder Treatment Revenue Market Share by 5542 (2012-2017) Figure Global Obsessive-Compulsive Disorder Treatment Revenue Market Share by 5542 in 2016 Table Global Obsessive-Compulsive Disorder Treatment Price (USD/Pcs) by 5542 (2012-2017) Table Global Obsessive-Compulsive Disorder Treatment Sales (K Pcs) by raglurant IR (2012-2017) Table Global Obsessive-Compulsive Disorder Treatment Sales Market Share by raglurant IR (2012-2017) Figure Global Obsessive-Compulsive Disorder Treatment Sales Market Share by raglurant IR in 2016 Table Global Obsessive-Compulsive Disorder Treatment Revenue (Million USD) by raglurant IR (2012-2017) Table Global Obsessive-Compulsive Disorder Treatment Revenue Market Share by raglurant IR (2012-2017) Figure Global Obsessive-Compulsive Disorder Treatment Revenue Market Share by raglurant IR in 2016 Table Global Obsessive-Compulsive Disorder Treatment Price (USD/Pcs) by raglurant IR (2012-2017) Table Global Obsessive-Compulsive Disorder Treatment Sales (K Pcs) by voxamine Maleate (2012-2017) Table Global Obsessive-Compulsive Disorder Treatment Sales Market Share by voxamine Maleate (2012-2017) Figure Global Obsessive-Compulsive Disorder Treatment Sales Market Share by voxamine Maleate in 2016 Table Global Obsessive-Compulsive Disorder Treatment Revenue (Million USD) by voxamine Maleate (2012-2017) Table Global Obsessive-Compulsive Disorder Treatment Revenue Market Share by voxamine Maleate (2012-2017) Figure Global Obsessive-Compulsive Disorder Treatment Revenue Market Share by voxamine Maleate in 2016 Table Global Obsessive-Compulsive Disorder Treatment Price (USD/Pcs) by voxamine Maleate (2012-2017) Figure United States Obsessive-Compulsive Disorder Treatment Revenue (Million USD) and Growth Rate (2012-2017) Figure United States Obsessive-Compulsive Disorder Treatment Sales Volume (K Pcs) and Growth Rate (2012-2017) Table United States Obsessive-Compulsive Disorder Treatment Sales (K Pcs) by -88178 (2012-2017) Table United States Obsessive-Compulsive Disorder Treatment Sales Market Share by -88178 (2012-2017) Figure United States Obsessive-Compulsive Disorder Treatment Sales Market Share by -88178 in 2016 Table United States Obsessive-Compulsive Disorder Treatment Revenue (Million USD) by -88178 (2012-2017) Table United States Obsessive-Compulsive Disorder Treatment Revenue Market Share by -88178 (2012-2017) Figure United States Obsessive-Compulsive Disorder Treatment Revenue Market Share by -88178 in 2016 Table United States Obsessive-Compulsive Disorder Treatment Price (USD/Pcs) by -88178 (2012-2017) Table United States Obsessive-Compulsive Disorder Treatment Sales (K Pcs) by opertin (2012-2017) Table United States Obsessive-Compulsive Disorder Treatment Sales Market Share by opertin (2012-2017) Figure United States Obsessive-Compulsive Disorder Treatment Sales Market Share by opertin in 2016 Table United States Obsessive-Compulsive Disorder Treatment Revenue (Million USD) by opertin (2012-2017) Table United States Obsessive-Compulsive Disorder Treatment Revenue Market Share by opertin (2012-2017) Figure United States Obsessive-Compulsive Disorder Treatment Revenue Market Share by opertin in 2016 Table United States Obsessive-Compulsive Disorder Treatment Price (USD/Pcs) by opertin (2012-2017) Table United States Obsessive-Compulsive Disorder Treatment Sales (K Pcs) by 5542 (2012-2017) Table United States Obsessive-Compulsive Disorder Treatment Sales Market Share by 5542 (2012-2017) Figure United States Obsessive-Compulsive Disorder Treatment Sales Market Share by 5542 in 2016 Table United States Obsessive-Compulsive Disorder Treatment Revenue (Million USD) by 5542 (2012-2017) Table United States Obsessive-Compulsive Disorder Treatment Revenue Market Share by 5542 (2012-2017) Figure United States Obsessive-Compulsive Disorder Treatment Revenue Market Share by 5542 in 2016 Table United States Obsessive-Compulsive Disorder Treatment Price (USD/Pcs) by 5542 (2012-2017) Table United States Obsessive-Compulsive Disorder Treatment Sales (K Pcs) by raglurant IR (2012-2017) Table United States Obsessive-Compulsive Disorder Treatment Sales Market Share by raglurant IR (2012-2017) Figure United States Obsessive-Compulsive Disorder Treatment Sales Market Share by raglurant IR in 2016 Table United States Obsessive-Compulsive Disorder Treatment Revenue (Million USD) by raglurant IR (2012-2017) Table United States Obsessive-Compulsive Disorder Treatment Revenue Market Share by raglurant IR (2012-2017) Figure United States Obsessive-Compulsive Disorder Treatment Revenue Market Share by raglurant IR in 2016 Table United States Obsessive-Compulsive Disorder Treatment Price (USD/Pcs) by raglurant IR (2012-2017) Table United States Obsessive-Compulsive Disorder Treatment Sales (K Pcs) by voxamine Maleate (2012-2017) Table United States Obsessive-Compulsive Disorder Treatment Sales Market Share by voxamine Maleate (2012-2017) Figure United States Obsessive-Compulsive Disorder Treatment Sales Market Share by voxamine Maleate in 2016 Table United States Obsessive-Compulsive Disorder Treatment Revenue (Million USD) by voxamine Maleate (2012-2017) Table United States Obsessive-Compulsive Disorder Treatment Revenue Market Share by voxamine Maleate (2012-2017) Figure United States Obsessive-Compulsive Disorder Treatment Revenue Market Share by voxamine Maleate in 2016 Table United States Obsessive-Compulsive Disorder Treatment Price (USD/Pcs) by voxamine Maleate (2012-2017) Table Global Obsessive-Compulsive Disorder Treatment Sales (K Pcs) by Regions (2012-2017) Table Global Obsessive-Compulsive Disorder Treatment Sales Share by Regions (2012-2017) Figure Global Obsessive-Compulsive Disorder Treatment Sales Market Share by Regions in 2016 Figure Global Obsessive-Compulsive Disorder Treatment Sales Market Share by Regions in 2017 Table Global Obsessive-Compulsive Disorder Treatment Revenue (Million USD) and Market Share by Regions (2012-2017) Table Global Obsessive-Compulsive Disorder Treatment Revenue Market Share by Regions (2012-2017) Figure Global Obsessive-Compulsive Disorder Treatment Revenue Market Share by Regions in 2016 Figure Global Obsessive-Compulsive Disorder Treatment Revenue Market Share by Regions in 2017 Table Global Obsessive-Compulsive Disorder Treatment Price (USD/Pcs) by Regions (2012-2017) Table North America Obsessive-Compulsive Disorder Treatment Sales (K Pcs) by Regions (2012-2017) Table North America Obsessive-Compulsive Disorder Treatment Revenue (Million USD) by Regions (2012-2017) Figure North America Obsessive-Compulsive Disorder Treatment Sales (K Pcs) and Growth Rate (2012-2017) Table United States Obsessive-Compulsive Disorder Treatment Sales (K Pcs) by Regions (2012-2017) Table United States Obsessive-Compulsive Disorder Treatment Revenue (Million USD) by Regions (2012-2017) Figure United States Obsessive-Compulsive Disorder Treatment Sales (K Pcs) and Growth Rate (2012-2017) Table Latin America Obsessive-Compulsive Disorder Treatment Sales (K Pcs) by Regions (2012-2017) Table Latin America Obsessive-Compulsive Disorder Treatment Revenue (Million USD) by Regions (2012-2017) Figure Latin America Obsessive-Compulsive Disorder Treatment Sales (K Pcs) and Growth Rate (2012-2017) Table Europe Obsessive-Compulsive Disorder Treatment Sales (K Pcs) by Regions (2012-2017) Table Europe Obsessive-Compulsive Disorder Treatment Revenue (Million USD) by Regions (2012-2017) Figure Europe Obsessive-Compulsive Disorder Treatment Sales (K Pcs) and Growth Rate (2012-2017) Table Asia & Pacific Obsessive-Compulsive Disorder Treatment Sales (K Pcs) by Regions (2012-2017) Table Asia & Pacific Obsessive-Compulsive Disorder Treatment Revenue (Million USD) by Regions (2012-2017) Figure Asia & Pacific Obsessive-Compulsive Disorder Treatment Sales (K Pcs) and Growth Rate (2012-2017) Table Africa & Middle East Obsessive-Compulsive Disorder Treatment Sales (K Pcs) by Regions (2012-2017) Table Africa & Middle East Obsessive-Compulsive Disorder Treatment Revenue (Million USD) by Regions (2012-2017) Figure Africa & Middle East Obsessive-Compulsive Disorder Treatment Sales (K Pcs) and Growth Rate (2012-2017) Table Global Obsessive-Compulsive Disorder Treatment Sales Volume (K Pcs) by Major Companies (2012-2017) Table Global Obsessive-Compulsive Disorder Treatment Sales Volume Market Share by Major Companies (2012-2017) Figure Global Obsessive-Compulsive Disorder Treatment Sales Volume Market Share by Major Companies 2016 Figure Global Obsessive-Compulsive Disorder Treatment Sales Volume Market Share by Major Companies 2017 Table Global Obsessive-Compulsive Disorder Treatment Revenue (Million USD) by Major Companies (2012-2017) Table Global Obsessive-Compulsive Disorder Treatment Revenue Market Share by Major Companies (2012-2017) Figure Global Obsessive-Compulsive Disorder Treatment Revenue Market Share by Major Companies 2016 Figure Global Obsessive-Compulsive Disorder Treatment Revenue Market Share by Major Companies 2017 Table Global Top Companies Key Product Model and Market Performance Table Global Top Companies Key Target Consumers and Market Performance Table United States Obsessive-Compulsive Disorder Treatment Sales Volume (K Pcs) by Top Companies (2012-2017) Table United States Obsessive-Compulsive Disorder Treatment Sales Volume Market Share by Top Companies (2012-2017) Figure United States Obsessive-Compulsive Disorder Treatment Sales Volume Market Share by Top Companies 2016 Figure United States Obsessive-Compulsive Disorder Treatment Sales Volume Market Share by Top Companies 2017 Table United States Obsessive-Compulsive Disorder Treatment Revenue (Million USD) by Top Companies (2012-2017) Table United States Obsessive-Compulsive Disorder Treatment Revenue Market Share by Top Companies (2012-2017) Figure United States Obsessive-Compulsive Disorder Treatment Revenue Market Share by Top Companies 2016 Figure United States Obsessive-Compulsive Disorder Treatment Revenue Market Share by Top Companies 2017 Table United States Top Companies Key Product Model and Market Performance Table United States Top Companies Key Target Consumers and Market Performance Table Global Obsessive-Compulsive Disorder Treatment Sales (K Pcs) by Consumer (2012-2017) Figure Global Obsessive-Compulsive Disorder Treatment Sales Market Share by Consumer (2012-2017) Figure Global Obsessive-Compulsive Disorder Treatment Sales Market Share by Consumer in 2016 Figure Global Clinic Obsessive-Compulsive Disorder Treatment Sales (K Pcs) and Growth Rate (2012-2017) Figure Global Hospital Obsessive-Compulsive Disorder Treatment Sales (K Pcs) and Growth Rate (2012-2017) Figure Global Research Center Obsessive-Compulsive Disorder Treatment Sales (K Pcs) and Growth Rate (2012-2017) Table United States Obsessive-Compulsive Disorder Treatment Sales (K Pcs) by Consumer (2012-2017) Figure United States Obsessive-Compulsive Disorder Treatment Sales Market Share by Consumer (2012-2017) Figure United States Obsessive-Compulsive Disorder Treatment Sales Market Share by Consumer in 2016 Figure United States Clinic Obsessive-Compulsive Disorder Treatment Sales (K Pcs) and Growth Rate (2012-2017) Figure United States Hospital Obsessive-Compulsive Disorder Treatment Sales (K Pcs) and Growth Rate (2012-2017) Figure United States Research Center Obsessive-Compulsive Disorder Treatment Sales (K Pcs) and Growth Rate (2012-2017) Table AbbVie Inc. Company Details and Competitors Table AbbVie Inc. Key Obsessive-Compulsive Disorder Treatment Models and Performance Table AbbVie Inc. Obsessive-Compulsive Disorder Treatment Business SWOT Analysis and Forecast Table AbbVie Inc. Obsessive-Compulsive Disorder Treatment Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017) Figure AbbVie Inc. Obsessive-Compulsive Disorder Treatment Sales (Million Unit) and Growth Rate (%)(2012-2017) Figure AbbVie Inc. Obsessive-Compulsive Disorder Treatment Sales Market Share (%) in Global (2012-2017) Figure AbbVie Inc. Obsessive-Compulsive Disorder Treatment Sales Revenue (Million USD) and Growth Rate (%)(2012-2017) Figure AbbVie Inc. Obsessive-Compulsive Disorder Treatment Revenue Market Share (%) in Global (2012-2017) Table Addex Therapeutics Ltd Company Details and Competitors Table Addex Therapeutics Ltd Key Obsessive-Compulsive Disorder Treatment Models and Performance Table Addex Therapeutics Ltd Obsessive-Compulsive Disorder Treatment Business SWOT Analysis and Forecast Table Addex Therapeutics Ltd Obsessive-Compulsive Disorder Treatment Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017) Figure Addex Therapeutics Ltd Obsessive-Compulsive Disorder Treatment Sales (Million Unit) and Growth Rate (%)(2012-2017) Figure Addex Therapeutics Ltd Obsessive-Compulsive Disorder Treatment Sales Market Share (%) in Global (2012-2017) Figure Addex Therapeutics Ltd Obsessive-Compulsive Disorder Treatment Sales Revenue (Million USD) and Growth Rate (%)(2012-2017) Figure Addex Therapeutics Ltd Obsessive-Compulsive Disorder Treatment Revenue Market Share (%) in Global (2012-2017) Table C4X Discovery Limited Company Details and Competitors Table C4X Discovery Limited Key Obsessive-Compulsive Disorder Treatment Models and Performance Table C4X Discovery Limited Obsessive-Compulsive Disorder Treatment Business SWOT Analysis and Forecast Table C4X Discovery Limited Obsessive-Compulsive Disorder Treatment Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017) Figure C4X Discovery Limited Obsessive-Compulsive Disorder Treatment Sales (Million Unit) and Growth Rate (%)(2012-2017) Figure C4X Discovery Limited Obsessive-Compulsive Disorder Treatment Sales Market Share (%) in Global (2012-2017) Figure C4X Discovery Limited Obsessive-Compulsive Disorder Treatment Sales Revenue (Million USD) and Growth Rate (%)(2012-2017) Figure C4X Discovery Limited Obsessive-Compulsive Disorder Treatment Revenue Market Share (%) in Global (2012-2017) Table F. Hoffmann-La Roche Ltd. Company Details and Competitors Table F. Hoffmann-La Roche Ltd. Key Obsessive-Compulsive Disorder Treatment Models and Performance Table F. Hoffmann-La Roche Ltd. Obsessive-Compulsive Disorder Treatment Business SWOT Analysis and Forecast Table F. Hoffmann-La Roche Ltd. Obsessive-Compulsive Disorder Treatment Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017) Figure F. Hoffmann-La Roche Ltd. Obsessive-Compulsive Disorder Treatment Sales (Million Unit) and Growth Rate (%)(2012-2017) Figure F. Hoffmann-La Roche Ltd. Obsessive-Compulsive Disorder Treatment Sales Market Share (%) in Global (2012-2017) Figure F. Hoffmann-La Roche Ltd. Obsessive-Compulsive Disorder Treatment Sales Revenue (Million USD) and Growth Rate (%)(2012-2017) Figure F. Hoffmann-La Roche Ltd. Obsessive-Compulsive Disorder Treatment Revenue Market Share (%) in Global (2012-2017) Table Novartis AG Company Details and Competitors Table Novartis AG Key Obsessive-Compulsive Disorder Treatment Models and Performance Table Novartis AG Obsessive-Compulsive Disorder Treatment Business SWOT Analysis and Forecast Table Novartis AG Obsessive-Compulsive Disorder Treatment Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017) Figure Novartis AG Obsessive-Compulsive Disorder Treatment Sales (Million Unit) and Growth Rate (%)(2012-2017) Figure Novartis AG Obsessive-Compulsive Disorder Treatment Sales Market Share (%) in Global (2012-2017) Figure Novartis AG Obsessive-Compulsive Disorder Treatment Sales Revenue (Million USD) and Growth Rate (%)(2012-2017) Figure Novartis AG Obsessive-Compulsive Disorder Treatment Revenue Market Share (%) in Global (2012-2017) Table Omeros Corporation Company Details and Competitors Table Omeros Corporation Key Obsessive-Compulsive Disorder Treatment Models and Performance Table Omeros Corporation Obsessive-Compulsive Disorder Treatment Business SWOT Analysis and Forecast Table Omeros Corporation Obsessive-Compulsive Disorder Treatment Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017) Figure Omeros Corporation Obsessive-Compulsive Disorder Treatment Sales (Million Unit) and Growth Rate (%)(2012-2017) Figure Omeros Corporation Obsessive-Compulsive Disorder Treatment Sales Market Share (%) in Global (2012-2017) Figure Omeros Corporation Obsessive-Compulsive Disorder Treatment Sales Revenue (Million USD) and Growth Rate (%)(2012-2017) Figure Omeros Corporation Obsessive-Compulsive Disorder Treatment Revenue Market Share (%) in Global (2012-2017) Table Rottapharm SpA Company Details and Competitors Table Rottapharm SpA Key Obsessive-Compulsive Disorder Treatment Models and Performance Table Rottapharm SpA Obsessive-Compulsive Disorder Treatment Business SWOT Analysis and Forecast Table Rottapharm SpA Obsessive-Compulsive Disorder Treatment Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017) Figure Rottapharm SpA Obsessive-Compulsive Disorder Treatment Sales (Million Unit) and Growth Rate (%)(2012-2017) Figure Rottapharm SpA Obsessive-Compulsive Disorder Treatment Sales Market Share (%) in Global (2012-2017) Figure Rottapharm SpA Obsessive-Compulsive Disorder Treatment Sales Revenue (Million USD) and Growth Rate (%)(2012-2017) Figure Rottapharm SpA Obsessive-Compulsive Disorder Treatment Revenue Market Share (%) in Global (2012-2017) Table Sellas Inc. Company Details and Competitors Table Sellas Inc. Key Obsessive-Compulsive Disorder Treatment Models and Performance Table Sellas Inc. Obsessive-Compulsive Disorder Treatment Business SWOT Analysis and Forecast Table Sellas Inc. Obsessive-Compulsive Disorder Treatment Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017) Figure Sellas Inc. Obsessive-Compulsive Disorder Treatment Sales (Million Unit) and Growth Rate (%)(2012-2017) Figure Sellas Inc. Obsessive-Compulsive Disorder Treatment Sales Market Share (%) in Global (2012-2017) Figure Sellas Inc. Obsessive-Compulsive Disorder Treatment Sales Revenue (Million USD) and Growth Rate (%)(2012-2017) Figure Sellas Inc. Obsessive-Compulsive Disorder Treatment Revenue Market Share (%) in Global (2012-2017) Figure Global Obsessive-Compulsive Disorder Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022) Figure Global Obsessive-Compulsive Disorder Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022) Figure Global Obsessive-Compulsive Disorder Treatment Price (USD/Pcs) Trend Forecast (2017-2022) Table Global Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by Regions (2017-2022) Table Global Obsessive-Compulsive Disorder Treatment Sales Volume Share Forecast by Regions (2017-2022) Figure Global Obsessive-Compulsive Disorder Treatment Sales Volume Share Forecast by Regions (2017-2022) Figure Global Obsessive-Compulsive Disorder Treatment Sales Volume Share Forecast by Regions in 2022 Table Global Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by Application (2017-2022) Figure Global Obsessive-Compulsive Disorder Treatment Sales Volume Market Share Forecast by Application (2017-2022) Figure Global Obsessive-Compulsive Disorder Treatment Sales Volume Market Share Forecast by Application in 2022 Table Global Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by -88178 (2017-2022) Figure Global Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by -88178 (2017-2022) Figure Global Obsessive-Compulsive Disorder Treatment Sales Volume Market Share Forecast by -88178 in 2022 Table Global Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by opertin (2017-2022) Figure Global Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by opertin (2017-2022) Figure Global Obsessive-Compulsive Disorder Treatment Sales Volume Market Share Forecast by opertin in 2022 Table Global Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by 5542 (2017-2022) Figure Global Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by 5542 (2017-2022) Figure Global Obsessive-Compulsive Disorder Treatment Sales Volume Market Share Forecast by 5542 in 2022 Table Global Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by raglurant IR (2017-2022) Figure Global Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by raglurant IR (2017-2022) Figure Global Obsessive-Compulsive Disorder Treatment Sales Volume Market Share Forecast by raglurant IR in 2022 Table Global Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by voxamine Maleate (2017-2022) Figure Global Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by voxamine Maleate (2017-2022) Figure Global Obsessive-Compulsive Disorder Treatment Sales Volume Market Share Forecast by voxamine Maleate in 2022 Figure United States Obsessive-Compulsive Disorder Treatment Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022) Figure United States Obsessive-Compulsive Disorder Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022) Figure United States Obsessive-Compulsive Disorder Treatment Price (USD/Pcs) Trend Forecast (2017-2022) Table United States Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by Regions (2017-2022) Table United States Obsessive-Compulsive Disorder Treatment Sales Volume Share Forecast by Regions (2017-2022) Figure United States Obsessive-Compulsive Disorder Treatment Sales Volume Share Forecast by Regions (2017-2022) Figure United States Obsessive-Compulsive Disorder Treatment Sales Volume Share Forecast by Regions in 2022 Table United States Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by Application (2017-2022) Figure United States Obsessive-Compulsive Disorder Treatment Sales Volume Market Share Forecast by Application (2017-2022) Figure United States Obsessive-Compulsive Disorder Treatment Sales Volume Market Share Forecast by Application in 2022 Table United States Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by -88178 (2017-2022) Figure United States Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by -88178 (2017-2022) Figure United States Obsessive-Compulsive Disorder Treatment Sales Volume Market Share Forecast by -88178 in 2022 Table United States Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by opertin (2017-2022) Figure United States Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by opertin (2017-2022) Figure United States Obsessive-Compulsive Disorder Treatment Sales Volume Market Share Forecast by opertin in 2022 Table United States Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by 5542 (2017-2022) Figure United States Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by 5542 (2017-2022) Figure United States Obsessive-Compulsive Disorder Treatment Sales Volume Market Share Forecast by 5542 in 2022 Table United States Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by raglurant IR (2017-2022) Figure United States Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by raglurant IR (2017-2022) Figure United States Obsessive-Compulsive Disorder Treatment Sales Volume Market Share Forecast by raglurant IR in 2022 Table United States Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by voxamine Maleate (2017-2022) Figure United States Obsessive-Compulsive Disorder Treatment Sales (K Pcs) Forecast by voxamine Maleate (2017-2022) Figure United States Obsessive-Compulsive Disorder Treatment Sales Volume Market Share Forecast by voxamine Maleate in 2022
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.